IN8bio, Inc (INAB) Prices 5.4M Share Offering at $1.90/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. PTC
4. MSFT
5. SPY
6. META
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to IN8bio, Inc (INAB) Prices 5.4M Share Offering at $1.90/sh

IN8bio Announces Pricing of $10.25 Million Underwritten Public Offering of Common Stock

August 11, 2022 10:05 PM EDT

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today announced the pricing of an underwritten public offering of 5,394,737 shares of its common stock at a public offering price of $1.90 per share. IN8bio also granted the underwriter a 30-day option to purchase up to an additional 657,894 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about August 16,... More